BTCRC-GI19-400

Prospective assessment of patients with neuroendocrine tumors and current or prior history of carcinoid syndrome or diarrhea undergoing peptide receptor radionuclide therapy with or without telotristat ethyl (NET-PACS Trial) Big Ten Cancer Research Consortium BTCRC-GI19-400

Status

Study Completed

Cancer Type(s)

Trial Locations

All sites in which the trial BTCRC-GI19-400 being conducted in.
No data was found